Antiviral Combination Clinically Better Than Standard Therapy in Severe but Not in Non-Severe COVID-19-Reference-Cited by-同舟云学术

Antiviral Combination Clinically Better Than Standard Therapy in Severe but Not in Non-Severe COVID-19

Published:2021-09 Issue: Volume:Volume 13 Page:185-195
ISSN:1179-1438
Container-title:Clinical Pharmacology: Advances and Applications
language:en
Short-container-title:CPAA

Author:

Panda Prasan Kumar^ORCID,Singh Budha O,Moirangthem Bikram,Bahurupi Yogesh Arvind,Saha Sarama,Saini Girraj,Dhar Minakshi,Bairwa Mukesh,Pai Venkatesh Srinivasa Pai,Agarwal Ankit,Sindhwani Girish,Handu Shailendra,Kant Ravi

Publisher

Informa UK Limited

Subject

Pharmacology (medical)

Reference22 articles.

1. Centers for Disease Control and Prevention. Evidence used to update the list of underlying medical conditions that increase a person’s risk of severe illness from COVID-19. US Dept Health Hum Serv. 2020;2019:1–6.

2. COVID-19 infection in kidney transplant recipients

3. Update: Characteristics of Symptomatic Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status — United States, January 22–October 3, 2020

4. Neurological Manifestations of COVID‐19: A systematic review and current update

5. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Challenges of consolidating evidence collected during a pandemic and lessons for the future;Current Medical Research and Opinion;2024-07-23

2. Efficacy and safety of casirivimab-imdevimab combination on COVID-19 patients: A systematic review and meta-analysis randomized controlled trial;Heliyon;2023-12

3. Profiles of Independent-Comorbidity Groups in Senior COVID-19 Patients Reveal Low Fatality Associated with Standard Care and Low-Dose Hydroxychloroquine over Antivirals [Letter];Journal of Multidisciplinary Healthcare;2023-05

4. COVID-19-related liver injury: Focus on genetic and drug-induced perspectives;World Journal of Virology;2023-01-25

5. Current Therapeutics for COVID-19, What We Know about the Molecular Mechanism and Efficacy of Treatments for This Novel Virus;International Journal of Molecular Sciences;2022-07-12